1.
纳入研究一般情况和质量评价
Statistics and assessment quality of included studies
| Trial | Paients (NO/NP) | Age (NO/NP) | Conslusion | Randomization | Allocated concealment | Blinding | Loss of follow-up |
| ORR: objective response rate; DCR: disease control rate; AEs: adverse effects; TP: time to progression; UA: unclear; NMT: not mentioned; DS: described. | |||||||
| Feng YH[4] | 25/25 | 62.50/63.30 | ORR, DCR, AEs | UA | UA | UA | NMT |
| Gao JF[5] | 58/32 | 63.50/63.00 | ORR, DCR, 1-year survival, TTP, OS, AEs | Random number table | UA | UA | DS |
| Huang P[6] | 25/23 | 73.00 | ORR, DCR, AEs | UA | UA | UA | DS |
| Liu MZ[7] | 40/42 | 60.00/57.00 | ORR, DCR, AEs | UA | UA | UA | NMT |
| Liu ZT[8] | 41/62 | 58.00/54.00 | ORR, DCR, AEs | UA | UA | UA | NMT |
| Li XW[9] | 25/25 | 58.00 | ORR, DCR, AEs | Simple random sampling | UA | UA | NMT |
| Li YC[10] | 26/24 | 68.00 | ORR, DCR, AEs | UA | UA | UA | NMT |
| Lu J[11] | 30/30 | 63.00/62.00 | ORR, DCR, AEs | UA | UA | UA | NMT |
| Ren L[12] | 83/85 | 56.00 | ORR, DCR, 1-year survival rate, AEs | UA | UA | UA | NMT |
| Wang XH[13] | 64/62 | 58.00/56.00 | ORR, DCR, AEs | UA | UA | UA | NMT |
| Wu YM[14] | 56/53 | 50.00 | ORR, AEs | UA | UA | UA | NMT |
| Yao WX[15] | 29/30 | 54.00 | ORR, DCR, AEs | Simple random sampling | UA | UA | NMT |
| Zhang XR[16] | 81/34 | 57.00/54.50 | ORR, DCR, TTP, 1-year survival, AEs | Block Random | UA | UA | DS |
| Zhang GL[17] | 34/36 | 57.00/56.00 | ORR, DCR, 1-year survival, AEs | UA | UA | UA | NMT |